Apexigen

Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.

Raised

$15M

Follow us

Companies in the same industry

Alexa global traffic share

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

08 Aug 2018

$15,000,000

Venture capital (Series B)

Decheng Capital